Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
Launch of adalimumab biosimilar Amjevita postponed
News
Ultrasound’s value for arthralgia may be to rule out IA
News
Risk factors for pulmonary hypertension identified in lupus patients
News
Radiographic progression in axial spondyloarthritis moves slowly in first 5 years
Video
VIDEO: Triple therapy study and new recommendations provide guidance on CAPS
News
Sacroiliac structural changes show on MRI in nonradiographic axial SpA despite no inflammation
News
FDA approves first new drug for ALS in decades
Video
VIDEO: Big research trials at AAN bring up important cost decisions
News
VIDEO: Pilot stem cell trial for multiple system atrophy shows promising results
News
Sepsis survivors may have high risk for seizures
News
Neurologists weigh in on rising drug prices
News
Ocrelizumab gets first-ever FDA approval for primary progressive MS
News
Methotrexate use justified for early RA, disease prevention
News
Opinions vary considerably on withdrawing drugs in clinically inactive JIA
News
